Tumor Profiling in Ovarian Cancer
With our advanced Technologies for Tumor Profiling, Creative Biolabs has developed a one-stop platform for ovarian tumor profiling.
Introduction of Tumor Profiling in Ovarian Cancer
Ovarian cancer is the most fatal gynecologic cancer, caused by drug resistance and intra-tumoral heterogeneity. A comprehensive multi-level landscape of ovarian cancer could be unraveled by genomic, transcriptomic, and proteomic technology, as shown in Fig.1. Ovarian cancer and its tumor microenvironment (TME) profiling could further identify pro-tumor factors and novel biomarkers, improve treatment effectiveness, and avoid resistance to chemotherapy.
Fig.1 Modern tumor profiling in ovarian cancer.1
Tumor Profiling in Ovarian Cancer at Creative Biolabs
- Technologies for ovarian tumor profiling
Recent advances in Technologies for Tumor Profiling have provided us insight into the genomic, epigenetic, and proteomic heterogeneity among ovary tumor cells. The technologies we provide for ovarian tumor profiling include but are not limited to:
Genomics
→Epigenetics
→- Whole Transcriptome Sequencing
- DNA Methylation
- RT-PCR (Reverse transcription PCR)
Epigenetics
→- IHC (Immunohistochemistry)
- Tissue Microarray
- ELISA (Enzyme-linked Immunosorbent Assay)
- List of some ovarian cancer biomarkers
- Workflow for ovarian tumor profiling
Features of Tumor Profiling in Ovarian Cancer at Creative Biolabs
Creative Biolabs provides a one-stop platform for ovarian tumor profiling. Our team of experts is dedicated to offering high-quality services that support novel ovarian cancer biomarker discovery and personalized immunotherapy advancement. If you are interested in our services, please feel free to contact us directly.
Reference
- Yang, Yanfei, et al. "Tumor microenvironment in ovarian cancer: function and therapeutic strategy." Frontiers in cell and developmental biology 8 (2020): 758. Distributed under Open Access license CC BY 4.0, without modification.
Download our brochure